Guggenheim reiterated their hold rating on shares of Keurig Dr Pepper (NYSE:KDP) in a research report released on Friday morning, TipRanks reports.
KDP has been the subject of several other research reports. Bank of America lifted their price target on shares of Keurig Dr Pepper from $30.00 to $33.00 and gave the stock a buy rating in a research report on Friday, August 9th. Royal Bank of Canada set a $31.00 price target on shares of Keurig Dr Pepper and gave the stock a buy rating in a research report on Friday, August 9th. BMO Capital Markets upgraded shares of Keurig Dr Pepper from a market perform rating to an outperform rating and lifted their price target for the stock from $27.00 to $34.00 in a research report on Monday, June 17th. Zacks Investment Research upgraded shares of Keurig Dr Pepper from a hold rating to a buy rating and set a $32.00 price target for the company in a research report on Wednesday, June 19th. Finally, Morgan Stanley set a $24.00 price target on shares of Keurig Dr Pepper and gave the stock a sell rating in a research report on Friday, August 9th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company. Keurig Dr Pepper currently has an average rating of Buy and a consensus price target of $30.27.
KDP traded up $0.32 during midday trading on Friday, hitting $27.32. The company had a trading volume of 1,508,564 shares, compared to its average volume of 2,545,028. Keurig Dr Pepper has a twelve month low of $22.19 and a twelve month high of $31.06. The firm’s 50-day simple moving average is $27.38 and its 200-day simple moving average is $28.16. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.23 and a current ratio of 0.33. The company has a market capitalization of $38.29 billion, a PE ratio of 26.27, a P/E/G ratio of 1.45 and a beta of 0.45.
Keurig Dr Pepper (NYSE:KDP) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.29 by $0.01. Keurig Dr Pepper had a net margin of 8.82% and a return on equity of 7.15%. The company had revenue of $2.81 billion during the quarter, compared to analysts’ expectations of $2.86 billion. During the same quarter in the previous year, the company earned $1.30 EPS. Keurig Dr Pepper’s revenue was up 196.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Keurig Dr Pepper will post 1.22 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 18th. Investors of record on Friday, October 4th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 2.20%. The ex-dividend date is Thursday, October 3rd. Keurig Dr Pepper’s payout ratio is 57.69%.
In other news, insider Brian Andrew Loucks acquired 18,554 shares of Keurig Dr Pepper stock in a transaction that occurred on Wednesday, August 14th. The shares were acquired at an average price of $28.31 per share, with a total value of $525,263.74. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert S. Singer acquired 3,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Tuesday, August 13th. The shares were purchased at an average cost of $28.65 per share, for a total transaction of $85,950.00. The disclosure for this purchase can be found here. Insiders have purchased a total of 68,727 shares of company stock worth $1,609,501 in the last three months. 0.44% of the stock is owned by insiders.
Institutional investors have recently added to or reduced their stakes in the stock. Jennison Associates LLC boosted its stake in Keurig Dr Pepper by 83.0% during the 1st quarter. Jennison Associates LLC now owns 863,468 shares of the company’s stock worth $24,151,000 after acquiring an additional 391,603 shares during the last quarter. Rehmann Capital Advisory Group lifted its stake in Keurig Dr Pepper by 2,827.3% in the first quarter. Rehmann Capital Advisory Group now owns 7,494 shares of the company’s stock valued at $210,000 after buying an additional 7,238 shares in the last quarter. MML Investors Services LLC bought a new position in Keurig Dr Pepper in the second quarter valued at approximately $233,000. AlphaCrest Capital Management LLC bought a new position in Keurig Dr Pepper in the first quarter valued at approximately $452,000. Finally, Jane Street Group LLC lifted its stake in Keurig Dr Pepper by 462.6% in the second quarter. Jane Street Group LLC now owns 376,042 shares of the company’s stock valued at $10,868,000 after buying an additional 309,203 shares in the last quarter. 19.53% of the stock is currently owned by institutional investors and hedge funds.
About Keurig Dr Pepper
Keurig Dr Pepper Inc operates as a beverage company in the United States and internationally. It operates through four segments: Beverage Concentrates, Packaged Beverages, Latin America Beverages, and Coffee Systems. The Beverage Concentrates segment manufactures and sells beverage concentrates. This segment also manufactures beverage concentrates into syrup.
Recommended Story: What is the cash asset ratio?
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.